Cargando…

Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk

(Hydroxy)chloroquine ((H)CQ) is being investigated as a treatment for COVID-19, but studies have so far demonstrated either no or a small benefit. However, these studies have been mostly performed in patients admitted to the hospital and hence likely already (severely) affected. Another suggested ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Offerhaus, Joost A., Wilde, Arthur A.M., Remme, Carol Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of Heart Rhythm Society. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332460/
https://www.ncbi.nlm.nih.gov/pubmed/32622993
http://dx.doi.org/10.1016/j.hrthm.2020.07.001